Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efalizumab for Eczema

This study has been completed.
Genentech, Inc.
Information provided by:
Rutgers, The State University of New Jersey Identifier:
First received: September 1, 2005
Last updated: August 6, 2008
Last verified: August 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: December 2007
  Estimated Primary Completion Date: No date given